Cartesian Therapeutics issues options for 121,900 shares to four new employees at $7.22 strike price
RNAC•Cartesian Therapeutics granted four new employees options covering 121,900 shares at a $7.22 exercise price on Oct. 1, 2026. The options vest through Oct. 1, 2030, and have a ten-year term.
1. Option grant terms
Cartesian Therapeutics granted four new employees options covering 121,900 shares on Oct. 1, 2026, at an exercise price of $7.22 per share, matching the Nasdaq closing price on the grant date. The options vest 25% on Oct. 1, 2027, then monthly until fully vested on Oct. 1, 2030, and have a ten-year term.
